Tom Hughes

Tom Hughes has more than 30 years of industry experience in the discovery, development, and commercial­iza­tion of pharmaceuti­cal products. Tom has served since 2018 as CEO of Navitor Pharmaceuti­cals, a privately held biopharmaceu­ti­cal company.

Prior to joining Navitor, Tom served as President and Chief Scientific Officer, and earlier as CEO of Zafgen Inc. Prior to Zafgen, Tom held several positions at Novartis including Global Head of the Cardiovascu­lar and Metabolic Diseases Therapeutic Area at the Novartis Institutes for BioMedical Research. He oversaw many drug discovery and development projects targeting major global aging-related health issues including obesity, diabetes, and heart disease.